
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published
For more information, click






